Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57–18, ABCSG-53, GBG 101)

Disagreement in genomically estimated risk exists in over 15 % of patients, potentially leading to over- or undertreatment. Consequently, the applicability of genomic tests in LNm remains controversial.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-06-18
DOI
https://doi.org/10.1016/j.ejca.2025.115585
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57–18, ABCSG-53, GBG 101)

Michael Knauer, Christoph Tausch, Vesna Bjelic‐Radisic, Susanne Bucher et al.
European Journal of Cancer
Breast Cancer Treatment Studies
article

Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57–18, ABCSG-53, GBG 101)

Michael Knauer, Christoph Tausch, Vesna Bjelic‐Radisic, Susanne Bucher, Valerijus Ostapenko, Inga Bekes, William Audeh, Andrea Menicucci, Ákos Sávolt, Daniel Egle, Stefanie Hayoz, Simone E. Muenst, Martin Heidinger, Rok Satler, Colin Simonson, William P. Weber, Christian Kurzeder, Giang Thanh Lam, Jörg Heil
article en

Abstract

Disagreement in genomically estimated risk exists in over 15 % of patients, potentially leading to over- or undertreatment. Consequently, the applicability of genomic tests in LNm remains controversial.

European Journal of CancerVol. 225
Witten/Herdecke University (DE), University of Lucerne (CH), University of Basel (CH), University of St.Gallen (CH), University Hospital of Basel (CH), Kantonsspital Winterthur (CH), University Hospital of Geneva (CH), National Institute of Oncology (HU), Breast Center (CH), OST - Ostschweizer Fachhochschule (CH), Agendia (Netherlands) (NL), Swiss Group For Clinical Cancer Research (CH), National Cancer Institute (LT), Austrian Breast & Colorectal Cancer Study Group (AT), Hôpital du Valais (CH)
Good health and well-being
Openalex Percentile: Top 80%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.